NSE filing, NSE: DECCANTRAN. Summary written from the filing by ALFA Finder's alert engine.
Deccan Transcon Leasing Ltd: key numbers
- Share price
- ₹18.80
- Market cap
- ₹42.72 Cr
- Revenue (annual)
- ₹166.3 Cr
- Net profit (annual)
- ₹6.18 Cr
- P/E (TTM)
- 6.9×Sector 30.1×
- Promoter holding
- 63.36%
- FII holding
- 1.86%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Deccan Transcon Leasing Ltd
All →Deccan Transcon Leasing Management Change
Mr. Rajeev Menon retires as the CEO and KMP of Deccan Transcon Leasing Limited, effective from the close of business hours on September 30, 2026.
Deccan Transcon Leasing Annual General Meeting
Deccan Transcon Leasing Limited held its 19th Annual General Meeting on September 29, 2026, via video conferencing to transact routine business and shareholder matters.
Deccan Transcon Leasing Annual General Meeting
Deccan Transcon Leasing Limited has issued a notice for its 19th Annual General Meeting on September 29, 2026. Key agenda items include adopting FY26 financial statements.
Deccan Transcon Leasing Annual Report
Deccan Transcon Leasing Limited submitted its FY 2025-26 Annual Report and notice for the 19th AGM. The meeting is scheduled for September 29, 2026.
Deccan Transcon Leasing Board Meeting Outcome
Deccan Transcon Leasing approved director re-appointment, Board's Report, AGM schedule, and appointments of internal, secretarial, and statutory auditors.
Deccan Transcon Leasing Management Change
Ms. Khushboo Gautam has resigned from her position as Company Secretary and Compliance Officer of Deccan Transcon Leasing Limited, effective August 25, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.